A leading pharmaceutical company faced significant challenges in protecting highly sensitive research data, including drug formulas and patient trial information, as employees increasingly adopted generative AI tools for research and analysis.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.